Insider Trading & Ownership of Christopher J. Coughlin

Summary
The estimated net worth of Christopher J. Coughlin is at least $2,984,784 dollars as of 31 Mar 2026. Christopher J. Coughlin is the Director of CENTENE CORP and owns shares of CENTENE CORP (CNC) stock worth about $2.21M. Christopher J. Coughlin is the Director of Prestige Consumer Healthcare Inc. and owns shares of Prestige Consumer Healthcare Inc. (PBH) stock worth about $778.8K.
Signature
/s/ Christopher A. Koster (executed by attorney-in-fact)
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher J. Coughlin and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Christopher J. Coughlin has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $2,984,784.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CENTENE CORP ($2,205,979).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher J. Coughlin

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CNC CENTENE CORP Director $2,205,979 31 Mar 2026
PBH Prestige Consumer Healthcare Inc. Director $778,805 02 Aug 2022
KRTX Karuna Therapeutics, Inc. Director $0 18 Mar 2024
ALXN ALEXION PHARMACEUTICALS, INC. Director 21 Jul 2021

Insider Transactions Reported by Christopher J. Coughlin:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .